[
    [
        {
            "time": "2018-01-02",
            "original_text": "Lawmakers grill top pharma execs over high drug costs",
            "features": {
                "keywords": [
                    "Lawmakers",
                    "grill",
                    "pharma",
                    "execs",
                    "high",
                    "drug",
                    "costs"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lawmakers grill top pharma execs over high drug costs",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-03",
            "original_text": "Congress Grills Drugmakers: 5 Key Takeaways",
            "features": {
                "keywords": [
                    "Congress",
                    "Grills",
                    "Drugmakers",
                    "Key",
                    "Takeaways"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Congress Grills Drugmakers: 5 Key Takeaways",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-04",
            "original_text": "CEOs From Pfizer, Merck and Others Face Senate Over Drug Pricing",
            "features": {
                "keywords": [
                    "CEOs",
                    "Pfizer",
                    "Merck",
                    "Senate",
                    "Drug",
                    "Pricing"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "CEOs From Pfizer, Merck and Others Face Senate Over Drug Pricing",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-05",
            "original_text": "Home Depot, Caterpillar stock declines weigh on indices",
            "features": {
                "keywords": [
                    "Home",
                    "Depot",
                    "Caterpillar",
                    "stock",
                    "declines",
                    "indices"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "retail",
                    "industrial"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Home Depot, Caterpillar stock declines weigh on indices",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-06",
            "original_text": "Why Big Pharma’s Case to Congress Comes Up Short",
            "features": {
                "keywords": [
                    "Big",
                    "Pharma",
                    "Case",
                    "Congress",
                    "Comes",
                    "Short"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Why Big Pharma’s Case to Congress Comes Up Short",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-07",
            "original_text": "There Are Many Reasons to Still Like AbbVie",
            "features": {
                "keywords": [
                    "Reasons",
                    "Like",
                    "AbbVie"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "There Are Many Reasons to Still Like AbbVie",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-08",
            "original_text": "Drugmakers’ CEOs clash with senators in hearing on drug price hikes",
            "features": {
                "keywords": [
                    "Drugmakers",
                    "CEOs",
                    "clash",
                    "senators",
                    "hearing",
                    "drug",
                    "price",
                    "hikes"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Drugmakers’ CEOs clash with senators in hearing on drug price hikes",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-09",
            "original_text": "Senators grill pharma execs for raising drug prices, protecting patents 'like Gollum with his ring'",
            "features": {
                "keywords": [
                    "Senators",
                    "grill",
                    "pharma",
                    "execs",
                    "raising",
                    "drug",
                    "prices",
                    "protecting",
                    "patents",
                    "Gollum",
                    "ring"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Senators grill pharma execs for raising drug prices, protecting patents 'like Gollum with his ring'",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-10",
            "original_text": "US drugmakers defend pricing under fire in Senate",
            "features": {
                "keywords": [
                    "US",
                    "drugmakers",
                    "defend",
                    "pricing",
                    "fire",
                    "Senate"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "US drugmakers defend pricing under fire in Senate",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]